Literature DB >> 21237679

The Possibility of differentiation between nonalcoholic steatohepatitis and fatty liver in rabbits on Gd-EOB-DTPA-enhanced open-type MRI scans.

Akinaga Sonoda1, Norihisa Nitta, Shinich Ohta, Ayumi Nitta-Seko, Keiko Tsuchiya, Yukihiro Nagatani, Kenichi Mukaisho, Masashi Takahashi, Kiyoshi Murata.   

Abstract

RATIONALE AND
OBJECTIVES: We used rabbits to investigate the possibility of differentiating between nonalcoholic steatohepatitis (NASH) and fatty liver (FL) on scans acquired by open-type‒ and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)‒enhanced magnetic resonance imaging (MRI).
MATERIALS AND METHODS: We divided 15 adult rabbits into three equal groups; they received standard (control group), high-fat (FL) content (FL group), or choline-deficient chow (NASH group). With the animals under general anesthesia we acquired scans on an open 0.3-Tesla MRI system. Signal intensity (SI) was measured before and after contrast administration and defined as SI-pre and SI-post, respectively. Relative SI enhancement (Sr) was calculated using the equation: Sr = (average of three SI-post- minus average of three SI values in no-signal fields)/(average of three SI-pre- minus average of three SI values in no-signal fields) × 100. Maximum Sr (Srmax), the time (in seconds) required to reach Srmax (Tmax), and the difference between Srmax and Sr at 30 minutes (Sr(30m)R) were analyzed.
RESULTS: Srmax was significantly higher in the NASH rabbits than the other two groups (P < .05).
CONCLUSIONS: In rabbits, the Srmax value made it possible to differentiate NASH from normal and fatty liver.
Copyright © 2011 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21237679     DOI: 10.1016/j.acra.2010.11.018

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  2 in total

1.  Imaging of focal nodular hyperplastic-like nodules in alcoholic liver cirrhosis patients using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging.

Authors:  Hisamitsu Miyaaki; Tatsuki Ichikawa; Naota Taura; Satoshi Miuma; Makiko Kawaguchi; Ryota Kohno; Hajime Isomoto; Fuminao Takeshima; Osamu Nakashima; Kazuhiko Nakao
Journal:  Clin J Gastroenterol       Date:  2011-07-14

2.  Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease.

Authors:  Ying Ding; Sheng-Xiang Rao; Tao Meng; Caizhong Chen; Renchen Li; Meng-Su Zeng
Journal:  Eur Radiol       Date:  2014-01-26       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.